Annual report
4480.TEDINET S100QGWO
Period2022-01-01 → 2022-12-31
Filed2023-03-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 132
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.2bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥10.9bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales |
| Revenue | ¥6.8bn | 2020-01-01 → 2020-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.8bn | 2019-01-01 → 2019-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.3bn | 2022-01-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥733m | 2021-01-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥1.5bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥743m | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥422m | 2020-01-01 → 2020-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥178m | 2019-01-01 → 2019-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.5bn | 2022-01-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥764m | 2021-01-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.0bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥563m | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥455m | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥381m | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.0bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥557m | 2021-01-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥21.8bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥20.2bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥15.5bn | at 2020-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥5.4bn | at 2019-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.6bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥6.2bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥15.2bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥14.0bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥9.7bn | at 2020-12-31d | Cons. | Net assets |
| Net assets / equity | ¥3.4bn | at 2019-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥14.4bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥14.3bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥14.4bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.1bn | at 2020-12-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.5bn | at 2019-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.0bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥805m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥513m | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥751m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.3bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥283m | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥767m | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥927m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥2.2bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥9.1bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.1bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥31.77 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.79 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.69 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-14.87 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥31.16 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥17.15 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥14.48 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥469.79 | at 2022-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥438.43 | at 2021-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥314.53 | at 2020-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥118.88 | at 2019-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 69.1% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.1% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.6% | at 2020-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.0% | at 2019-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.0% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.7% | 2021-01-01 → 2021-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.0% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 895 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 719 | at 2021-12-31 | Cons. | Number of employees |
| Employees | 494 | at 2020-12-31d | Cons. | Number of employees |
| Employees | 379 | at 2019-12-31d | Cons. | Number of employees |
| Revenue | ¥11.6bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥9.0bn | 2021-01-01 → 2021-12-31 | Standalone | Net sales |
| Revenue | ¥6.7bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.7bn | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.9bn | 2018-01-01 → 2018-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.4bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Operating income | ¥743m | 2021-01-01 → 2021-12-31 | Standalone | Operating income |
| Ordinary income | ¥1.7bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥770m | 2021-01-01 → 2021-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥433m | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥186m | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥87m | 2018-01-01 → 2018-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.7bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥770m | 2021-01-01 → 2021-12-31 | Standalone | Income before income taxes |
| Net income | ¥1.2bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | ¥653m | 2021-01-01 → 2021-12-31 | Standalone | Profit loss |
| Net income | ¥467m | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥381m | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥153m | 2018-01-01 → 2018-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥20.5bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥18.8bn | at 2021-12-31 | Standalone | Assets |
| Total assets | ¥15.4bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥5.4bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.3bn | at 2018-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.1bn | at 2022-12-31 | Standalone | Liabilities |
| Total liabilities | ¥4.8bn | at 2021-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥15.4bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥14.1bn | at 2021-12-31 | Standalone | Net assets |
| Net assets / equity | ¥9.7bn | at 2020-12-31d | Standalone | Net assets |
| Net assets / equity | ¥3.4bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.1bn | at 2018-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥13.1bn | at 2022-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥13.4bn | at 2021-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥37.48 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.64 | 2021-01-01 → 2021-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.09 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-14.87 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.88 | 2018-01-01 → 2018-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥36.75 | 2022-01-01 → 2022-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥19.9 | 2021-01-01 → 2021-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥14.85 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥479.42 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥441.63 | at 2021-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥314.91 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥118.88 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥41.26 | at 2018-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 75.1% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.7% | at 2021-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.0% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.2% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.6% | at 2018-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 8.1% | 2022-01-01 → 2022-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.5% | 2021-01-01 → 2021-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 32,706,800 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 32,462,500 | at 2021-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 30,889,100 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 28,145,100 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 26,094,400 | at 2018-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 699 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 589 | at 2021-12-31 | Standalone | Number of employees |
| Employees | 474 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 365 | at 2019-12-31d | Standalone | Number of employees |
| Employees | 246 | at 2018-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 70
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-01-01 → 2022-12-31 | ¥99m |
| Reconciling Itemsreconciling | depreciation | 2022-01-01 → 2022-12-31 | ¥48m |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-12-31 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-12-31 | −¥2m |
| Reconciling Itemsreconciling | segment assets | at 2022-12-31 | ¥18.9bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | −¥2.4bn |
| Medical Platform Businessreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥374m |
| Medical Platform Businessreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥139m |
| Medical Platform Businessreportable segment | employees | at 2022-12-31 | 356 pure |
| Medical Platform Businessreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥3.7bn |
| Medical Platform Businessreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥3.7bn |
| Medical Platform Businessreportable segment | segment assets | at 2022-12-31 | ¥2.1bn |
| Medical Platform Businessreportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥535m |
| New Development Servicesreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥0 |
| New Development Servicesreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥0 |
| New Development Servicesreportable segment | employees | at 2022-12-31 | 38 pure |
| New Development Servicesreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥326m |
| New Development Servicesreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥326m |
| New Development Servicesreportable segment | segment assets | at 2022-12-31 | ¥2m |
| New Development Servicesreportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥75m |
| Recruitment Platform Businessreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥394m |
| Recruitment Platform Businessreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥198m |
| Recruitment Platform Businessreportable segment | employees | at 2022-12-31 | 393 pure |
| Recruitment Platform Businessreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥10.1bn |
| Recruitment Platform Businessreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥10.1bn |
| Recruitment Platform Businessreportable segment | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥2m |
| Recruitment Platform Businessreportable segment | segment assets | at 2022-12-31 | ¥808m |
| Recruitment Platform Businessreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥4.3bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-01-01 → 2022-12-31 | ¥769m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-01-01 → 2022-12-31 | ¥338m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-01-01 → 2022-12-31 | ¥14.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-01-01 → 2022-12-31 | ¥14.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-12-31 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-01-01 → 2022-12-31 | ¥3.7bn |
| Reconciling Itemsreconciling | capex | 2021-01-01 → 2021-12-31 | ¥53m |
| Reconciling Itemsreconciling | depreciation | 2021-01-01 → 2021-12-31 | ¥31m |
| Reconciling Itemsreconciling | revenue | 2021-01-01 → 2021-12-31 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-01 → 2021-12-31 | ¥0 |
| Reconciling Itemsreconciling | segment assets | at 2021-12-31 | ¥17.5bn |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-12-31 | −¥2.0bn |
| Medical Platform Businessreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥2.1bn |
| Medical Platform Businessreportable segment | depreciation | 2021-01-01 → 2021-12-31 | ¥100m |
| Medical Platform Businessreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥2.7bn |
| Medical Platform Businessreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥2.7bn |
| Medical Platform Businessreportable segment | segment assets | at 2021-12-31 | ¥2.0bn |
| Medical Platform Businessreportable segment | segment profit | 2021-01-01 → 2021-12-31 | −¥457m |
| New Development Servicesreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥0 |
| New Development Servicesreportable segment | depreciation | 2021-01-01 → 2021-12-31 | ¥0 |
| New Development Servicesreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥308m |
| New Development Servicesreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥308m |
| New Development Servicesreportable segment | segment assets | at 2021-12-31 | ¥0 |
| New Development Servicesreportable segment | segment profit | 2021-01-01 → 2021-12-31 | −¥41m |
| Recruitment Platform Businessreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥619m |
| Recruitment Platform Businessreportable segment | depreciation | 2021-01-01 → 2021-12-31 | ¥175m |
| Recruitment Platform Businessreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥7.9bn |
| Recruitment Platform Businessreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥7.9bn |
| Recruitment Platform Businessreportable segment | revenue intersegment | 2021-01-01 → 2021-12-31 | ¥0 |
| Recruitment Platform Businessreportable segment | segment assets | at 2021-12-31 | ¥681m |
| Recruitment Platform Businessreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥3.2bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-01-01 → 2021-12-31 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-01-01 → 2021-12-31 | ¥276m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-01-01 → 2021-12-31 | ¥10.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-01-01 → 2021-12-31 | ¥10.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-01-01 → 2021-12-31 | ¥0 |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-12-31 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-01-01 → 2021-12-31 | ¥2.7bn |
| Medical Platform Businessreportable segment | employees | at 2022-12-31 | 167 pure |
| New Development Servicesreportable segment | employees | at 2022-12-31 | 32 pure |
| Recruitment Platform Businessreportable segment | employees | at 2022-12-31 | 392 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,476
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | 604800 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 320849 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 32084900 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 17100 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 32706800 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 320849 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 604800 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 604800 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0185 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 604800 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 604800 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0185 | |
| Number of male directors and other officers | FilingDateInstant | 6 | |
| Number of female directors and other officers | FilingDateInstant | 3 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.33 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E33586-000TakiguchiKoheiMember | 5989400 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E33586-000KawaharaRyoMember | 391800 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E33586-000KotaniNoboruMember | 42000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E33586-000RinaSakurabaMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E33586-000ReikoNagatsumaMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E33586-000KeisukeHiokiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E33586-000OmoteShoheiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E33586-000KamachiMasahideMember | 11400 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E33586-000RyokoNagataMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 6434600 | |
| Audit fees reporting company | Prior1YearDuration | 65000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | － | JPY |
| Audit fees reporting company | CurrentYearDuration | 63000000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | － | JPY |
| Audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Audit fees total | Prior1YearDuration | 65000000 | JPY |
| Non audit fees total | Prior1YearDuration | － | JPY |
| Audit fees total | CurrentYearDuration | 63000000 | JPY |
| Non audit fees total | CurrentYearDuration | － | JPY |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 173000000 | JPY |
| Cash remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 152000000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | － | JPY |
| Non monetary remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 20000000 | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 7 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 14000000 | JPY |
| Cash remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 14000000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | JPY |
| Non monetary remuneration remuneration by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |